Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs NDAQ✓SelectedUSD · NDAQMRNA vs NDAQ performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs NDAQ

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-31.0%
NDAQ return
+58.7%
Excess return
-89.7%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioNDAQExcessAlpha
1D-2.2%-1.0%-1.2%-1.7%
7D-12.7%-5.1%-7.6%-10.4%
30D-20.7%+7.1%-27.7%-23.8%
3M+46.3%+5.9%+40.4%+41.1%
6M+305.2%+15.1%+290.1%+266.9%
YTD+561.2%+7.0%+554.2%+521.8%
1Y+772.1%+19.9%+752.2%+663.1%
3Y+147.0%+97.9%+49.0%+47.6%
All-31.0%+58.7%-89.7%-54.4%

Cumulative growth

Daily Returns

Daily percentage return beside NDAQ.

Daily Out/Under-Performance

Portfolio return minus NDAQ return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × NDAQ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded NDAQ wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling